Hopp til hovedinnhold

Autonome nevropatier (kroniske)

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Dineen J1, Freeman R1. Autonomic Neuropathy.. Semin Neurol. 2015; Aug;35(4): 458-68. pmid:26502768 PubMed  
  2. Kaur D, Tiwana H, Stino A, Sandroni P. Autonomic neuropathies. Muscle Nerve. 2020 Sep 14. PMID: 32926436. PubMed  
  3. Koike H, Watanabe H, Sobue G. The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. J Neurol Neurosurg Psychiatry. 2012. pmid:22906617 PubMed  
  4. Mendoza-Santiesteban CE, Palma JA, Norcliffe-Kaufmann L, Kaufmann H. Familial dysautonomia: a disease with hidden tears. J Neurol. 2017 Jun;264(6):1290-1291 . pmid:28401297 PubMed  
  5. Metzler M, Duerr S, Granata R, Krismer F, Robertson D, Wenning GK.. Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management.. J Neurol. 2013 ; 260: 2212-9. pmid:23180176 PubMed  
  6. Benarroch EE. The clinical approach to autonomic failure in neurological disorders. Nat Rev Neurol 2014; 10: 396-407. pmid:24866874 PubMed  
  7. Palma JA, Kaufmann H. Management of Orthostatic Hypotension. Continuum (Minneap Minn). 2020 Feb;26(1):154-177. PMID: 31996627 PubMed  
  8. Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP, Thijs RD. Diagnosis and treatment of orthostatic hypotension. Lancet Neurol. 2022 Aug;21(8):735-746. doi: 10.1016/S1474-4422(22)00169-7. PMID: 35841911. PubMed  
  9. Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI. Orthostatic Hypotension: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018 Sep 11;72(11):1294-1309. PMID: 30190008 PubMed  
  10. Izcovich A, González Malla C, Manzotti M, Catalano HN, Guyatt G. Midodrine for orthostatic hypotension and recurrent reflex syncope: A systematic review. Neurology 2014; 83: 1170-7. pmid:25150287 PubMed  
  11. Kaufmann H.. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.. Clin Auton Res. 2008; 18: 1924. pmid:18368303 PubMed  
  12. Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, Mauney J, Feirtag M, Mathias CJ; NOH301 Investigators. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 2014; 83: 328-35. pmid:24944260 PubMed  
  13. Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Grubb BP.. Use of octreotide in the treatment of refractory orthostatic intolerance.. Am J Ther. 2012; 19: 7-10. pmid:20535001 PubMed  
  14. Newton JL, Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018 Aug 14;91(7):e652-e656. PMID: 30006412 PubMed  
  15. Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes. 2018 Jan 15;9(1):1-24. PMID: 29359025 PubMed  
  16. Y Lei L, S Chew D, K Sandhu R, S Sheldon R, R Raj S. Non-Pharmacological and Pharmacological Management of Cardiac Dysautonomia Syndromes. J Atr Fibrillation. 2020 Jun 30;13(1):2395. PMID: 33024496 PubMed  
  17. Koike H, Koyano S, Morozumi S, Kawagashira Y, Iijima M, Katsuno M, Hattori N, Vernino S, Sobue G.. Slowly progressive autonomic neuropathy with antiganglionic acetylcholine receptor antibody. J Neurol Neurosurg Psychiatry. 2010; 81: 586-7. pmid:20460600 PubMed  
  18. Grubb AF, Grubb BP. Postural Orthostatic Tachycardia Syndrome: New Concepts in Pathophysiology and Management. Trends Cardiovasc Med. 2021 Oct 22:S1050-1738(21)00122-5. doi: 10.1016/j.tcm.2021.10.007. Epub ahead of print. PMID: 34695573. PubMed  
  19. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz IJ, Schondorf R, Stewart JM, van Dijk JG.. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.. Auton Neurosci. 2011 ; 161: 46-8. pmid:21393070 PubMed  
  20. Kanjwal K1, Saeed B, Karabin B, Kanjwal Y, Grubb BP.. Clinical presentation and management of patients with hyperadrenergic postural orthostatic tachycardia syndrome. A single center experience. Cardiol J. 2011; 18(5): 527-31. pmid:21947988 PubMed  
  21. Shibata S, Fu Q, Bivens TB, Hastings JL, Wang W, Levine BD.. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome.. J Physiol. 2012; 590: 3495-505. pmid:22641777 PubMed  
  22. Tahir F, Bin Arif T, Majid Z, Ahmed J, Khalid M. Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature. Cureus. 2020 Apr 28;12(4):e7868. PMID: 32489723 PubMed  
  23. Taub PR, Zadourian A, Lo HC, Ormiston CK, Golshan S, Hsu JC. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome. J Am Coll Cardiol. 2021 Feb 23;77(7):861-871. doi:
  24. Arnold AC, Okamoto LE, Diedrich A, Paranjape SY, Raj SR, Biaggioni I, Gamboa A. Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study.. Neurology 2013; 80: 1927-33. pmid:23616163 PubMed  
  25. Jones PK, Shaw BH, Raj SR. Clinical challenges in the diagnosis and management of postural tachycardia syndrome. Pract Neurol. 2016 Sep 22 . pmid:27660311 PubMed  
  26. Rodriguez B, Hoepner R, Salmen A, Kamber N, Z'Graggen WJ. Immunomodulatory treatment in postural tachycardia syndrome: A case series. Eur J Neurol. 2021 May;28(5):1692-1697. doi: 10.1111/ene.14711. Epub 2021 Jan 19. PMID: 33382525. PubMed  
  27. Kesterson K, Schofield J, Blitshteyn S. Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS). J Neurol. 2022 Aug 26. doi: 10.1007/s00415-022-11344-z. Epub ahead of print. PMID: 36008726. PubMed  
  28. Wells R, Hissaria P, Elliott AD, Sanders P, Page A, Baumert M, Lau DH. Plasma Exchange Therapy in Postural Tachycardia Syndrome: A Novel Long-Term Approach? Am J Med. 2020 Apr;133(4):e157-e159. PMID: 31715171. PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Kvalitetsutvalget NFKNF